IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Biodexa Pharmaceuticals PLC

CUSIP: 59564R708 | 17 institutional holders

Quarters

Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2024

UBS Group AG255,446
0.0% of portfolio›$72.0K
Two Sigma Securities, LLC32,577
0.0% of portfolio›$9.2K
Morgan Stanley14,320
0.0% of portfolio›$4.0K
Rhumbline Advisers6,038
0.0% of portfolio›$1.7K
Contravisory Investment Management, Inc.1,000
0.0% of portfolio›$282
Gamma Investing LLC287
0.0% of portfolio›$81
Hantz Financial Services, Inc.30
0.0% of portfolio›$0
Proequities, Inc.0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
UBS Group AG
255,446$72.0K0.0%CoreMediumZurich, Switzerland2024-11-14
Two Sigma Securities, LLC
32,577$9.2K0.0%ValueVery HighNew York, NY2024-11-14
Morgan Stanley
14,320$4.0K0.0%CoreLowNew York, NY2025-05-14
Rhumbline Advisers
6,038$1.7K0.0%IndexVery LowBoston, MA2024-11-12
Contravisory Investment Management, Inc.
1,000$2820.0%MomentumHighNorwell, MA2024-10-09
Gamma Investing LLC
287$810.0%IndexVery LowFoster City, CA2024-10-07
Hantz Financial Services, Inc.
30$00.0%CoreMediumSouthfield, MI2024-11-14
Proequities, Inc.
0$00.0%GrowthVery LowBirmingham, AL2024-10-10